glp-1 receptor agonists effectiveness comparison Drug in Diabetes and Obesity Treatment Research shows GLP-1 receptor agonist

GoF receptors are often characterised by a greater propensity for G protein versus -arrestin recruitment and signalling, slower rate of receptor internalisation and rapid recycling back to the plasma membrane, with these characteristics being independent of their surface expression levels (Liu et al., 2022)

However, it comes at a cost

The company saw an impressive 56% year-over-year (YOY) boost to revenue, thanks in large part to $12.8 billion in combined sales of its two main GLP-1 agonists, Mounjaro and Zepbound

2025;8(1):p

For broader clinical context, the ADA Standards of Care provide evolving guidance on indications, monitoring, and safety considerations for GLP-1based therapies

Without adequate protein intake and resistance exercise, muscle loss accelerates